Apricot Capital
Asia, Shanghai, China, Shanghai'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry.
Investor Profile
Apricot Capital has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series D, Seed rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Biopharma, Biotechnology, Health Care.
Stage Focus
- Series Unknown (33%)
- Series D (33%)
- Seed (33%)
Country Focus
- China (67%)
- United States (33%)
Industry Focus
- Biopharma
- Biotechnology
- Health Care
- Life Science
- Therapeutics
- Medical
- Medical Device
- Precision Medicine
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
